Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Alcami.

    Client Virtual Booth

    ALCAMI

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Alcami
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2320 Scientific Park DriveWilmington, North Carolina
    Telephone
    Telephone
    (800) 575-4224
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alcaminow.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alcami-corporation
    Twitter
    Twitter
    https://twitter.com/alcaminow

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products

    Details:

    PharmaTher is evolving to become a leader in ketamine-based solutions for mental health, neurological and pain disorders, and partnering with Alcami as our exclusive manufacturer for the clinical and commercial supply of ketamine.


    Lead Product(s): Ketamine Hydrochloride

    Therapeutic Area: Neurology Product Name: Undisclosed

    Highest Development Status: Phase I/ Phase IIProduct Type: Small molecule

    Recipient: PharmaTher

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement October 19, 2021

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Alcami Providing Commercial Manufacturing for Trevena’s Recently FDA Approved OLINVYK

    Details:

    Alcami is providing commercial manufacturing services for Trevena's newly approved OLINVYK. OLINVYK (oliceridine) injection is an opioid approved in adults for the management of acute pain severe enough to require an intravenous opioid analgesic.


    Lead Product(s): Oliceridine

    Therapeutic Area: Neurology Product Name: Olinvyk

    Highest Development Status: ApprovedProduct Type: Small molecule

    Partner/Sponsor/Collaborator: Trevena

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement August 26, 2020

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search